5 things to know about Hookipa Pharma ahead of its IPO

Hookipa Pharma Inc., a biotech that’s using arenavirus-based platforms to develop treatments targeting infectious diseases and cancers, set terms for its initial public offering shares this week, saying it will offer 6.7 million shares priced at $14 to $16 each.